Live Research Database
Psoriasis
Hub: Omaha, NE
Connecting patients in Omaha with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Nebraska
Available Psoriasis Opportunities
3 RecruitingNCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT07474792(Verify)
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
RECRUITING
Psoriasis
NCT05669833(Verify)
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Omaha through safe, transparent, and patient-first clinical trials."
Research Hubs in Omaha
Explore other local breakthroughs
Psoriasis Hubs in NE
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT